Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methanococcus vannielii Proteasome-activating nucleotidase (pan) CSB-YP409372MNS
CSB-EP409372MNS
CSB-BP409372MNS
CSB-MP409372MNS
CSB-EP409372MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii DNA polymerase sliding clamp (pcn) CSB-YP409373MNS
CSB-EP409373MNS
CSB-BP409373MNS
CSB-MP409373MNS
CSB-EP409373MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Translation initiation factor 6 (eif6) CSB-YP409374MNS
CSB-EP409374MNS
CSB-BP409374MNS
CSB-MP409374MNS
CSB-EP409374MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Acetylglutamate kinase (argB) CSB-YP409375MNS
CSB-EP409375MNS
CSB-BP409375MNS
CSB-MP409375MNS
CSB-EP409375MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii 50S ribosomal protein L21e (rpl21e) CSB-YP409376MNS
CSB-EP409376MNS
CSB-BP409376MNS
CSB-MP409376MNS
CSB-EP409376MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP409377MNS
CSB-EP409377MNS
CSB-BP409377MNS
CSB-MP409377MNS
CSB-EP409377MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii 50S ribosomal protein L39e (rpl39e) CSB-YP409378MNS
CSB-EP409378MNS
CSB-BP409378MNS
CSB-MP409378MNS
CSB-EP409378MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii 7-cyano-7-deazaguanine synthase (queC) CSB-YP409379MNS
CSB-EP409379MNS
CSB-BP409379MNS
CSB-MP409379MNS
CSB-EP409379MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii DNA-directed RNA polymerase subunit L (rpoL) CSB-YP409380MNS
CSB-EP409380MNS
CSB-BP409380MNS
CSB-MP409380MNS
CSB-EP409380MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Translation initiation factor 2 subunit beta (eIF2B) CSB-YP409381MNS
CSB-EP409381MNS
CSB-BP409381MNS
CSB-MP409381MNS
CSB-EP409381MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Uridylate kinase (pyrH) CSB-YP409382MNS
CSB-EP409382MNS
CSB-BP409382MNS
CSB-MP409382MNS
CSB-EP409382MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Probable bifunctional tRNA threonylcarbamoyladenosine biosynthesis protein (Mevan_1404), partial CSB-YP409383MNS
CSB-EP409383MNS
CSB-BP409383MNS
CSB-MP409383MNS
CSB-EP409383MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii 50S ribosomal protein L34e (rpl34e) CSB-YP409384MNS
CSB-EP409384MNS
CSB-BP409384MNS
CSB-MP409384MNS
CSB-EP409384MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Uracil phosphoribosyltransferase (upp) CSB-YP409385MNS
CSB-EP409385MNS
CSB-BP409385MNS
CSB-MP409385MNS
CSB-EP409385MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii Proline--tRNA ligase (proS) CSB-YP409386MNS
CSB-EP409386MNS
CSB-BP409386MNS
CSB-MP409386MNS
CSB-EP409386MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus vannielii UPF0145 protein Mevan_1624 (Mevan_1624) CSB-YP409387MNS
CSB-EP409387MNS
CSB-BP409387MNS
CSB-MP409387MNS
CSB-EP409387MNS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus aeolicus 50S ribosomal protein L10e (rpl10e) CSB-YP409388MNO
CSB-EP409388MNO
CSB-BP409388MNO
CSB-MP409388MNO
CSB-EP409388MNO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus aeolicus V-type ATP synthase subunit D (atpD) CSB-YP409389MNO
CSB-EP409389MNO
CSB-BP409389MNO
CSB-MP409389MNO
CSB-EP409389MNO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus aeolicus 50S ribosomal protein L31e (rpl31e) CSB-YP409390MNO
CSB-EP409390MNO
CSB-BP409390MNO
CSB-MP409390MNO
CSB-EP409390MNO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus aeolicus Protein Maeo_0138 (Maeo_0138) CSB-YP409391MNO
CSB-EP409391MNO
CSB-BP409391MNO
CSB-MP409391MNO
CSB-EP409391MNO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>